These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15472864)

  • 1. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.
    Wang WK; Chen SY; Liu IJ; Kao CL; Chen HL; Chiang BL; Wang JT; Sheng WH; Hsueh PR; Yang CF; Yang PC; Chang SC;
    Clin Infect Dis; 2004 Oct; 39(7):1071-5. PubMed ID: 15472864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.
    Tang JW; To KF; Lo AW; Sung JJ; Ng HK; Chan PK
    J Med Virol; 2007 Sep; 79(9):1245-53. PubMed ID: 17607787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.
    Peiris JS; Chu CM; Cheng VC; Chan KS; Hung IF; Poon LL; Law KI; Tang BS; Hon TY; Chan CS; Chan KH; Ng JS; Zheng BJ; Ng WL; Lai RW; Guan Y; Yuen KY;
    Lancet; 2003 May; 361(9371):1767-72. PubMed ID: 12781535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum cytokines in patients with severe acute respiratory syndrome.
    Zhang Y; Li J; Zhan Y; Wu L; Yu X; Zhang W; Ye L; Xu S; Sun R; Wang Y; Lou J
    Infect Immun; 2004 Aug; 72(8):4410-5. PubMed ID: 15271897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
    Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
    Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
    Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW
    Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
    Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
    Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
    Wang Y; Li W; Jiang Z; Xi X; Zhu Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22379. PubMed ID: 32957417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids.
    Ward SE; Loutfy MR; Blatt LM; Siminovitch KA; Chen J; Hinek A; Wolff B; Pham DH; Deif H; LaMere EA; Kain KC; Farcas GA; Ferguson P; Latchford M; Levy G; Fung L; Dennis JW; Lai EK; Fish EN
    Antivir Ther; 2005; 10(2):263-75. PubMed ID: 15865221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
    Bitnun A; Allen U; Heurter H; King SM; Opavsky MA; Ford-Jones EL; Matlow A; Kitai I; Tellier R; Richardson S; Manson D; Babyn P; Read S;
    Pediatrics; 2003 Oct; 112(4):e261. PubMed ID: 14523209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome.
    Sheng WH; Chiang BL; Chang SC; Ho HN; Wang JT; Chen YC; Hsiao CH; Hseuh PR; Chie WC; Yang PC
    J Formos Med Assoc; 2005 Oct; 104(10):715-23. PubMed ID: 16385373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral loads in clinical specimens and SARS manifestations.
    Hung IF; Lau SK; Woo PC; Yuen KY
    Hong Kong Med J; 2009 Dec; 15 Suppl 9():20-2. PubMed ID: 20393220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
    Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
    Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 16. Ribavirin for SARS in children.
    Cheng WT; Li CK; Leung TF; Li AM; Hon KL; Ng PC; Fok TF
    Clin Pediatr (Phila); 2004 Mar; 43(2):193-6. PubMed ID: 15024445
    [No Abstract]   [Full Text] [Related]  

  • 17. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
    Tsui PT; Kwok ML; Yuen H; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome.
    Christian MD; Poutanen SM; Loutfy MR; Muller MP; Low DE
    Clin Infect Dis; 2004 May; 38(10):1420-7. PubMed ID: 15156481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.
    Tsang K; Seto WH
    Curr Opin Investig Drugs; 2004 Feb; 5(2):179-85. PubMed ID: 15043392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.